These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19819830)

  • 1. Floating drug delivery of a locally acting H2-antagonist: an approach using an in situ gelling liquid formulation.
    Rohith G; Sridhar BK; Srinatha A
    Acta Pharm; 2009 Sep; 59(3):345-54. PubMed ID: 19819830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
    Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, in vitro and in vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy.
    Ishak RA; Awad GA; Mortada ND; Nour SA
    J Control Release; 2007 Jun; 119(2):207-14. PubMed ID: 17412443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan.
    El Maghraby GM; Elzayat EM; Alanazi FK
    Drug Dev Ind Pharm; 2012 Aug; 38(8):971-8. PubMed ID: 22092113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
    Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of polysaccharide gel-coated pellets for oral administration. 2. Calcium alginate.
    Sriamornsak P; Kennedy RA
    Eur J Pharm Sci; 2006 Oct; 29(2):139-47. PubMed ID: 16919918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation.
    Shadab ; Ahuja A; Khar RK; Baboota S; Chuttani K; Mishra AK; Ali J
    Drug Deliv; 2011 May; 18(4):255-64. PubMed ID: 21110695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stomach-specific drug delivery of 5-fluorouracil using floating alginate beads.
    Shishu ; Gupta N; Aggarwal N
    AAPS PharmSciTech; 2007 Jun; 8(2):Article 48. PubMed ID: 17625805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of hydrophilic matrix tablets based on Carbopol(®) 971P and low-viscosity sodium alginate for pH-independent controlled drug release.
    Al-Zoubi NM; AlKhatib HS; Obeidat WM
    Drug Dev Ind Pharm; 2011 Jul; 37(7):798-808. PubMed ID: 21247372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alginate microspheres obtained by the spray drying technique as mucoadhesive carriers of ranitidine.
    Szekalska M; Amelian A; Winnicka K
    Acta Pharm; 2015 Mar; 65(1):15-27. PubMed ID: 25781701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation.
    Dave BS; Amin AF; Patel MM
    AAPS PharmSciTech; 2004 Apr; 5(2):e34. PubMed ID: 15760092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric floating matrix tablets: design and optimization using combination of polymers.
    Prajapati ST; Patel LD; Patel DM
    Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and characterization of calcium-free in-situ gel formulation based on sodium alginate and chitosan.
    Belhadji L; HadjSadok A; Moulai-Mostefa N
    Drug Dev Ind Pharm; 2018 Apr; 44(4):662-669. PubMed ID: 29172753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alginate drug delivery systems: application in context of pharmaceutical and biomedical research.
    Jain D; Bar-Shalom D
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1576-84. PubMed ID: 25109399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan-alginate multilayer beads for controlled release of ampicillin.
    Anal AK; Stevens WF
    Int J Pharm; 2005 Feb; 290(1-2):45-54. PubMed ID: 15664129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the influencing factors on the drug release from sodium alginate matrices].
    Nie SF; Wu XM; Liu HF; Jiang HW; Pan WS
    Yao Xue Xue Bao; 2004 Jul; 39(7):561-5. PubMed ID: 15493851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
    Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
    Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral controlled release formulation for highly water-soluble drugs: drug--sodium alginate--xanthan gum--zinc acetate matrix.
    Zeng WM
    Drug Dev Ind Pharm; 2004 May; 30(5):491-5. PubMed ID: 15244084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability.
    Patil S; Talele GS
    Drug Deliv; 2015 May; 22(3):312-9. PubMed ID: 24471787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.